Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) FCF Margin (2021 - 2025)

PAVmed has reported FCF Margin over the past 5 years, most recently at 1876.54% for Q4 2025.

  • For Q4 2025, FCF Margin fell 277654.0% year-over-year to 1876.54%; the TTM value through Dec 2025 reached 5237.0%, down 442598.0%, while the annual FY2025 figure was 5237.0%, 411483.0% down from the prior year.
  • FCF Margin for Q4 2025 was 1876.54% at PAVmed, up from 18060.0% in the prior quarter.
  • Over five years, FCF Margin peaked at 900.0% in Q4 2024 and troughed at 25864.47% in Q3 2022.
  • A 5-year average of 8351.24% and a median of 5022.25% in 2021 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: plummeted -2183797bps in 2022 and later skyrocketed 2446030bps in 2023.
  • Year by year, FCF Margin stood at 6018.0% in 2021, then tumbled by -154bps to 15286.61% in 2022, then skyrocketed by 92bps to 1149.38% in 2023, then skyrocketed by 178bps to 900.0% in 2024, then tumbled by -309bps to 1876.54% in 2025.
  • Business Quant data shows FCF Margin for PAVM at 1876.54% in Q4 2025, 18060.0% in Q3 2025, and 20133.33% in Q2 2025.